Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))

Anabela Barcelos; David G. Lopes; Helena Canhão; Jaime da Cunha Branco; Ana Maria Rodrigues

doi:10.1016/j.bonr.2023.101691

Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))

Anabela Barcelos, David G. Lopes, Helena Canhão, Jaime da Cunha Branco, Ana Maria Rodrigues

Research output: Contribution to journal › Comment/debate › peer-review

4 Downloads (Pure)

Abstract

The authors regret that the printed version of the above article missed to include the funding details. The correct and final version follows. The authors would like to apologise for any inconvenience caused. The present publication was funded by Fundação para a Ciência e a Tecnologia, IP national support through CHRC (UIDB/04923/2020). The study was supported by unrestricted grants from Direcção-Geral da Saúde, aFundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbvie, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Center de Medicina Laboratorial Germano de Sousa, Clínica Médica da Praia da Vitória, CAL-Clínica, Galp Energia, Açoreana Seguros, and individual rheumatologists.

Original language	English
Article number	101691
Journal	Bone Reports
DOIs	https://doi.org/10.1016/j.bonr.2023.101691
Publication status	E-pub ahead of print - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bonr.2023.101691

1-s2.0-S2352187223000396-mainProof, 249 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))'. Together they form a unique fingerprint.

Cite this

Barcelos, A., Lopes, D. G., Canhão, H., da Cunha Branco, J., & Rodrigues, A. M. (2023). Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139)). Bone Reports, [101691]. https://doi.org/10.1016/j.bonr.2023.101691

@article{219194a4ee0c4fb0b36ec768c9a12220,

title = "Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))",

abstract = "The authors regret that the printed version of the above article missed to include the funding details. The correct and final version follows. The authors would like to apologise for any inconvenience caused. The present publication was funded by Funda{\c c}{\~a}o para a Ci{\^e}ncia e a Tecnologia, IP national support through CHRC (UIDB/04923/2020). The study was supported by unrestricted grants from Direc{\c c}{\~a}o-Geral da Sa{\'u}de, aFunda{\c c}{\~a}o Calouste Gulbenkian, Funda{\c c}{\~a}o Champalimaud, Funda{\c c}{\~a}o AstraZeneca, Abbvie, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Center de Medicina Laboratorial Germano de Sousa, Cl{\'i}nica M{\'e}dica da Praia da Vit{\'o}ria, CAL-Cl{\'i}nica, Galp Energia, A{\c c}oreana Seguros, and individual rheumatologists.",

author = "Anabela Barcelos and Lopes, {David G.} and Helena Canh{\~a}o and {da Cunha Branco}, Jaime and Rodrigues, {Ana Maria}",

note = "Funding Information: The present publication was funded by Funda{\c c}{\~a}o para a Ci{\^e}ncia e a Tecnologia , IP national support through CHRC ( UIDB/04923/2020 ). Publisher Copyright: {\textcopyright} 2023 The Author(s)",

year = "2023",

doi = "10.1016/j.bonr.2023.101691",

language = "English",

journal = "Bone Reports",

issn = "2352-1872",

publisher = "Elsevier Inc.",

}

Barcelos, A , Lopes, DG , Canhão, H , da Cunha Branco, J & Rodrigues, AM 2023, 'Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))', Bone Reports. https://doi.org/10.1016/j.bonr.2023.101691

Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139)). / Barcelos, Anabela ; Lopes, David G.; Canhão, Helena et al.
In: Bone Reports, 2023.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older

T2 - A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))

AU - Barcelos, Anabela

AU - Lopes, David G.

AU - Canhão, Helena

AU - da Cunha Branco, Jaime

AU - Rodrigues, Ana Maria

PY - 2023

Y1 - 2023

N2 - The authors regret that the printed version of the above article missed to include the funding details. The correct and final version follows. The authors would like to apologise for any inconvenience caused. The present publication was funded by Fundação para a Ciência e a Tecnologia, IP national support through CHRC (UIDB/04923/2020). The study was supported by unrestricted grants from Direcção-Geral da Saúde, aFundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbvie, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Center de Medicina Laboratorial Germano de Sousa, Clínica Médica da Praia da Vitória, CAL-Clínica, Galp Energia, Açoreana Seguros, and individual rheumatologists.

AB - The authors regret that the printed version of the above article missed to include the funding details. The correct and final version follows. The authors would like to apologise for any inconvenience caused. The present publication was funded by Fundação para a Ciência e a Tecnologia, IP national support through CHRC (UIDB/04923/2020). The study was supported by unrestricted grants from Direcção-Geral da Saúde, aFundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbvie, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Center de Medicina Laboratorial Germano de Sousa, Clínica Médica da Praia da Vitória, CAL-Clínica, Galp Energia, Açoreana Seguros, and individual rheumatologists.

UR - http://www.scopus.com/inward/record.url?scp=85163211619&partnerID=8YFLogxK

U2 - 10.1016/j.bonr.2023.101691

DO - 10.1016/j.bonr.2023.101691

M3 - Comment/debate

AN - SCOPUS:85163211619

SN - 2352-1872

JO - Bone Reports

JF - Bone Reports

M1 - 101691

ER -

Barcelos A , Lopes DG , Canhão H , da Cunha Branco J , Rodrigues AM. Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139)). Bone Reports. 2023;101691. Epub 2023. doi: 10.1016/j.bonr.2023.101691

Corrigendum to “Multimorbidity is associated with fragility fractures in women 50 years and older: A nationwide cross-sectional study” [Bone Rep. 15 (2021) 101139 (December)] (Bone Reports (2021) 15, (S235218722100396X), (10.1016/j.bonr.2021.101139))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this